GLP-3RT 12MG

$300.00

GLP-3RT 12MG is a GGG tri-agonist research peptide that activates GLP-1, GIP, and glucagon receptors, enhancing basal metabolism while supporting appetite control and delayed gastric emptying. This multi-receptor activity provides a broader approach to obesity research compared to traditional GLP-1 agonists.

GLP-3RT is a synthetic GLP-based peptide analogue of approximately 30–35 amino acids with a molecular weight of ~3,500–4,200 Da and ≥99% research-grade purity. It is supplied as a white to off-white lyophilized powder in 12 mg vials for in vitro and laboratory research use only.

Category:
Description

GLP-3RT 12MG is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, thereby increasing basal metabolism. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.

Chemical Information

  • Chemical Name: GLP-3RT (Glucagon-Like Peptide–based Research Tri-Modified / RT variant)
  • Molecular Formula: — (peptide; exact formula varies based on proprietary modifications and salt form)
  • Molecular Weight: ~3,500–4,200 Da (approximate; manufacturer dependent)
  • Peptide Length: ~30–35 amino acids (GLP-based analogue)
  • Classification: Synthetic peptide hormone analogue (GLP receptor–related research peptide)
  • Purity: ≥99% (HPLC, research grade)
  • Appearance: White to off-white lyophilized powder
  • Net Content: 12 mg

Additional Information

  • Sequence Description: Modified GLP-based peptide incorporating stabilization and resistance-enhancing structural changes
  • CAS Number: Not assigned / not universally registered
  • Salt Form: Typically acetate or TFA (manufacturer dependent)

Storage Conditions

  • Store lyophilized powder at –20 °C or below
  • Protect from light, heat, and moisture
  • Avoid repeated freeze–thaw cycles after reconstitution

Intended Use

  • For research use only (RUO)
  • Intended for in vitro and laboratory research applications
  • Not for human or veterinary use

Clinical Data:

  • GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
  • GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
  • GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
Additional information
Size

1MG (1000MCG)

,

2MG (2000MCG)

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “GLP-3RT 12MG”

Your email address will not be published. Required fields are marked *